Novel approaches for glioblastoma treatment: Focus on tumor heterogeneity, treatment resistance, and computational tools

作者: Silvana Valdebenito , Daniela D'Amico , Eliseo Eugenin , None

DOI: 10.1002/CNR2.1220

关键词: Tumor heterogeneityBioinformaticsGlioblastomaBrain tumorTemozolomideTreatment resistanceComplete resectionMedicineCancer stem cellRadiation therapy

摘要: Background Glioblastoma (GBM) is a highly aggressive primary brain tumor. Currently, the suggested line of action surgical resection followed by radiotherapy and treatment with adjuvant temozolomide, DNA alkylating agent. However, ability tumor cells to deeply infiltrate surrounding tissue makes complete quite impossible, and, in consequence, probability recurrence high, prognosis not positive. GBM heterogeneous adapts most individuals. Nevertheless, these mechanisms adaption are unknown. Recent findings In this review, we will discuss recent discoveries molecular cellular heterogeneity, therapeutic resistance, new technological approaches identify treatments for GBM. The combination biology computer resources allow use algorithms apply artificial intelligence machine learning potential pathways drug candidates. Conclusion These generate better understanding pathogenesis result novel reduce or block devastating consequences cancers.

参考文章(156)
Kenneth Aldape, Gelareh Zadeh, Sheila Mansouri, Guido Reifenberger, Andreas von Deimling, Glioblastoma: pathology, molecular mechanisms and markers Acta Neuropathologica. ,vol. 129, pp. 829- 848 ,(2015) , 10.1007/S00401-015-1432-1
Tracy Seymour, Anna Nowak, Foteini Kakulas, Targeting Aggressive Cancer Stem Cells in Glioblastoma. Frontiers in Oncology. ,vol. 5, pp. 159- 159 ,(2015) , 10.3389/FONC.2015.00159
Matthew S. Waitkus, Bill H. Diplas, Hai Yan, Isocitrate dehydrogenase mutations in gliomas. Neuro-oncology. ,vol. 18, pp. 16- 26 ,(2016) , 10.1093/NEUONC/NOV136
Tiara M. Forsyth, Wenya Linda Bi, Malak Abedalthagafi, Ian F. Dunn, E. Antonio Chiocca, Extracranial growth of glioblastoma multiforme Journal of Clinical Neuroscience. ,vol. 22, pp. 1521- 1523 ,(2015) , 10.1016/J.JOCN.2015.03.018
Justin D. Lathia, Stephen C. Mack, Erin E. Mulkearns-Hubert, Claudia L.L. Valentim, Jeremy N. Rich, Cancer stem cells in glioblastoma Genes & Development. ,vol. 29, pp. 1203- 1217 ,(2015) , 10.1101/GAD.261982.115
X Wang, H-H Gerdes, Transfer of mitochondria via tunneling nanotubes rescues apoptotic PC12 cells Cell Death & Differentiation. ,vol. 22, pp. 1181- 1191 ,(2015) , 10.1038/CDD.2014.211
Jeffrey A. Magee, Elena Piskounova, Sean J. Morrison, Cancer Stem Cells: Impact, Heterogeneity, and Uncertainty Cancer Cell. ,vol. 21, pp. 283- 296 ,(2012) , 10.1016/J.CCR.2012.03.003
Qiang Huang, Quan-Bin Zhang, Jun Dong, Yin-Yan Wu, Yun-Tian Shen, Yao-Dong Zhao, Yu-De Zhu, Yi Diao, Ai-Dong Wang, Qing Lan, Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro BMC Cancer. ,vol. 8, pp. 304- 304 ,(2008) , 10.1186/1471-2407-8-304
Motoo Nagane, Soichiro Shibui, Hiroshi Oyama, Akio Asai, Yoshiyuki Kuchino, Kazuhiro Nomura, Investigation of chemoresistance-related genes mRNA expression for selecting anticancer agents in successful adjuvant chemotherapy for a case of recurrent glioblastoma. Surgical Neurology. ,vol. 44, pp. 462- 470 ,(1995) , 10.1016/0090-3019(95)00299-5
E. Vlashi, C. Lagadec, L. Vergnes, T. Matsutani, K. Masui, M. Poulou, R. Popescu, L. Della Donna, P. Evers, C. Dekmezian, K. Reue, H. Christofk, P. S. Mischel, F. Pajonk, Metabolic state of glioma stem cells and nontumorigenic cells Proceedings of the National Academy of Sciences of the United States of America. ,vol. 108, pp. 16062- 16067 ,(2011) , 10.1073/PNAS.1106704108